摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-溴-3-苯基丙酸 | 35016-63-8

中文名称
(S)-2-溴-3-苯基丙酸
中文别名
(S)-α-溴苯丙酸;S-2-溴-3-苯基丙酸
英文名称
(S)-2-bromo-3-phenylpropionic acid
英文别名
(S)-2-bromo-3-phenylpropanoic acid;(2S)-2-bromo-3-phenylpropanoic acid
(S)-2-溴-3-苯基丙酸化学式
CAS
35016-63-8
化学式
C9H9BrO2
mdl
——
分子量
229.073
InChiKey
WDRSCFNERFONKU-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    145-155°C
  • 沸点:
    301.6±22.0 °C(Predicted)
  • 密度:
    1.558±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿(少量)、DMSO(少量)、甲醇(少量)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2916399090
  • 安全说明:
    S26
  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P301+P330+P331,P303+P361+P353,P363,P304+P340,P310,P321,P260,P264,P280,P305+P351+P338,P405,P501
  • 危险品运输编号:
    3261
  • 危险性描述:
    H314
  • 储存条件:
    室温

SDS

SDS:abbdc9ad84c74657377e977a912a401b
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product name : (S)-2-Bromo-3-phenylpropionic acid

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
According to Regulation (EC) No1272/2008
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
According to European Directive 67/548/EEC as amended.
Irritating to eyes, respiratory system and skin.
Label elements
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Hazard symbol(s)
Xi Irritant
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
Caution - substance not yet tested completely.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
: (S)-α-Bromobenzenepropanoic acid
Synonyms
Formula : C9H9BrO2
Molecular Weight : 229,07 g/mol
CAS-No. EC-No. Index-No. Classification Concentration
(S)-2-Bromo-3-phenylpropionic acid
35016-63-8 - - Skin Irrit. 2; Eye Irrit. 2; STOT -
SE 3; H315, H319, H335
Xi, R36/37/38
For the full text of the H-Statements mentioned in this Section, see Section 16.

Section 4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
Conditions for safe storage
Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully
resealed and kept upright to prevent leakage. Store in cool place.
Store under inert gas.

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Personal protective equipment
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with
multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to
engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves
after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Eye protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin and body protection
impervious clothing, The type of protective equipment must be selected according to the concentration
and amount of the dangerous substance at the specific workplace.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form liquid
Colour dark brown
Safety data
pH no data available
Melting point no data available
Boiling point no data available
Flash point no data available
Ignition temperature no data available
Lower explosion limit no data available
Upper explosion limit no data available
Water solubility no data available
Partition coefficient: log Pow: 2,5
n-octanol/water

Section 10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Conditions to avoid
no data available
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, Hydrogen bromide gas

Section 11. TOXICOLOGICAL INFORMATION
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional
waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
ADR/RID
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.

Section 16. OTHER INFORMATION
Text of H-code(s) and R-phrase(s) mentioned in Section 3
Eye Irrit. Eye irritation
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Skin Irrit. Skin irritation
STOT SE Specific target organ toxicity - single exposure
Xi Irritant
R36/37/38 Irritating to eyes, respiratory system and skin.
Further information
Copyright 2010 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee
of the properties of the product. Co., shall not be held liable for any damage resulting from
handling or from contact with the above product. See reverse side of invoice or packing slip for additional
terms and conditions of sale.

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-2-溴-3-苯基丙酸一水合肼 作用下, 以 乙醇 为溶剂, 以45%的产率得到(S)-2-hydrazinyl-3-phenylpropanoic acid
    参考文献:
    名称:
    肼肽和缀合物的合成
    摘要:
    (α-苄氧羰基-氨基酰基)苯并三唑化物(Cbz = 苄氧羰基)在微波辐射下与 α-肼酸发生偶联反应,形成杂合肼二肽(42-71%)。β-N-Cbz-α-肼基酰基苯并三唑化物的手性酰化成功地用 N-、S-、O-和 C-亲核试剂进行,产率为 49-88%。
    DOI:
    10.1002/ejoc.201201731
  • 作为产物:
    描述:
    L-苯丙氨酸氢溴酸 、 sodium nitrite 作用下, 以 为溶剂, 以97%的产率得到(S)-2-溴-3-苯基丙酸
    参考文献:
    名称:
    由芳香氨基酸直接合成α-硫代芳香酸
    摘要:
    修饰氨基酸是化学和生物学中有用的合成成分。在这里,我们描述了一种简单、可扩展的两步程序,用于从芳香氨基酸生成 α-硫代芳香酸,收率高达 96%。重氮化和α-内酯介导的溴化有效地形成α-溴酸并保留构型。用温和的试剂(例如硫氢化钠或三硫代碳酸钠)取代硫醇,得到反向的游离α-硫代酸。然后,弱酸性软亲核试剂可用于许多合成应用。
    DOI:
    10.1016/j.tetlet.2018.02.030
点击查看最新优质反应信息

文献信息

  • Preparation and Evaluation at the Delta Opioid Receptor of a Series of Linear Leu-Enkephalin Analogues Obtained by Systematic Replacement of the Amides
    作者:Kristina Rochon、Arnaud Proteau-Gagné、Philippe Bourassa、Jean-François Nadon、Jérome Côté、Véronique Bournival、Fernand Gobeil、Brigitte Guérin、Yves L. Dory、Louis Gendron
    DOI:10.1021/cn4000583
    日期:2013.8.21
    receptor (DOPr). The lipophilicity (LogD7.4) and plasma stability of the active analogues were also measured. Our results revealed that the last amide bond can be successfully replaced by either an ester or an N-methyl amide bond without significantly decreasing the biological activity of the corresponding analogues when compared to Leu-enkephalin. The peptidomimetics with an N-methyl amide function between
    使用经典有机化学和固相肽合成 (SPPS) 制备亮脑啡肽类似物,其中酰胺键被酯或N-甲基酰胺键顺序和系统地取代。使用竞争结合、ERK1/2 磷酸化、受体内化和收缩性测定来表征肽模拟物,以评估它们对 delta 阿片受体 (DOPr) 的药理学特征。还测量了活性类似物的亲脂性(LogD 7.4 )和血浆稳定性。我们的结果表明,最后一个酰胺键可以被酯或N成功取代与亮脑啡肽相比,-甲基酰胺键不会显着降低相应类似物的生物活性。发现在残基 Phe 和 Leu 之间具有N-甲基酰胺功能的肽模拟物比 Leu-脑啡肽更亲脂且更稳定。本研究的结果进一步表明,亮脑啡肽的第四个酰胺的氢键供体性质对其对 DOPr 的生物活性并不重要。我们的结果表明,用等排功能系统地替换酰胺键代表了一种设计和合成具有增强稳定性的新型肽类似物的有效方法。我们的研究结果进一步表明,这种策略也可用于研究酰胺键的生物学作用。
  • Nucleophilic Substitution Reactions of Alkyl Halides by Using New Polymer-Supported Reagents Containing Hemin
    作者:Kiyoshi Saito、Kaoru Harada
    DOI:10.1246/bcsj.62.2562
    日期:1989.8
    hemin, divinylbenzene, and 2-methyl-5-vinylpyridine was synthesized by suspension copolymerization. Substitution reactions of primary, secondary, and tertiary alkyl halides with the hemin copolymer combined with cyanide, azide, and thiocyanate ions were given satisfactory yields. This reaction mechanism was revealed to be a SNi type on the basis of stereochemical study. The hemin copolymer was not only
    通过悬浮共聚反应合成了一种由化血红素、二乙烯基苯2-甲基-5-乙烯基吡啶组成的新型高分子试剂。伯、仲和叔烷基卤与化血红素共聚物与化物、叠氮化物硫氰酸根离子的取代反应得到了令人满意的产率。根据立体化学研究,该反应机理被揭示为 SNi 型。化血红素共聚物不仅是具有功能性的聚合物负载试剂,而且还用于将产物与反应混合物分离。
  • Stereoselective Synthesis of γ-Lactams from Imines and Cyanosuccinic Anhydrides
    作者:Darlene Q. Tan、Ashkaan Younai、Ommidala Pattawong、James C. Fettinger、Paul Ha-Yeon Cheong、Jared T. Shaw
    DOI:10.1021/ol402554n
    日期:2013.10.4
    A reaction between imines and anhydrides has been developed with chiral disubstituted anhydrides and chiral imines. The synthesis of highly substituted γ-lactams with three stereogenic centers, including one quaternary center, proceeds at room temperature in high yield and with high diastereoselectivity in most cases. Enantiomerically pure alkyl-substituted anhydrides proceed with no epimerization
    亚胺和酸酐之间的反应已经开发出手性二取代酸酐和手性亚胺。具有三个立体中心(包括一个四元中心)的高度取代的 γ-内酰胺的合成在室温下以高产率进行,并且在大多数情况下具有高非对映选择性。对映体纯的烷基取代酸酐不进行差向异构化,从而提供对映体纯的五取代内酰胺产品的途径。
  • Ruthenium(II)–Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells
    作者:Liam J. Stephens、Aviva Levina、Iman Trinh、Victoria L. Blair、Melissa V. Werrett、Peter A. Lay、Philip C. Andrews
    DOI:10.1002/cbic.201900676
    日期:2020.4.17
    RuII -arene complexes provide a versatile scaffold for novel anticancer drugs. Seven new RuII -arene-thiocarboxylato dimers were synthesized and characterized. Three of the complexes (2 a, b and 5) showed promising antiproliferative activities in MDA-MB-231 (human invasive breast cancer) cells, and were further tested in a panel of fifteen cancerous and noncancerous cell lines. Complex 5 showed moderate
    RuII-芳烃配合物为新型抗癌药物提供了多功能支架。合成并表征了七个新的RuII-芳烃-代羧酰二聚体。三种复合物(2a,b和5)在MDA-MB-231(人类浸润性乳腺癌)细胞中显示出有希望的抗增殖活性,并在一组15种癌性和非癌性细胞系中进行了进一步测试。复合物5在MDA-MB-231细胞中表现出中等但显着的选择性活性(IC50 = 39±4μmRu)。实时增殖研究表明5诱导了MDA-MB-231细胞凋亡,但对A549(人肺癌,上皮)细胞无影响。相比之下,2 a和b在这两种细胞系中均显示出中等的抗增殖活性,但没有凋亡。侵袭性细胞的选择性细胞毒性为5,
  • (R)- and (S)-3-hydroxy-4,4-dimethyl-1-phenyl-2-pyrrolidinone as chiral auxiliaries for the asymmetric synthesis of α-hydroxy acids
    作者:Pelayo Camps、Francesc Pérez、Núria Soldevilla
    DOI:10.1016/s0957-4166(97)00176-6
    日期:1997.6
    Rac-α-bromo acids, rac-4, have been converted into (R)- or (S)-α-hydroxy acid, (R)- or (S)-9, by DCC-induced esterification with the chiral auxiliaries (R)- or (S)-1, followed by reaction with sodium p-methoxyphenoxide in the presence of tetra-n-hexylammonium iodide, conditions of dynamic kinetic resolution, to give quite diastereoselectively the (αR,3S)- or esters, 7, which were then oxidized with
    Rac - α-溴酸rac-4已通过DCC诱导与手性助剂的酯化反应转化为(R)-或(S)-α-羟基酸(R)-或(S)-9 ( R)-或(S)-1 ,然后在动态动力学拆分条件下,在化四-正己基铵盐存在下与对甲氧基苯甲酸钠反应,以非对映选择性生成(αR,3S)-或酯7然后将其用硝酸铈铵氧化,并在控制的酸性条件下解。
查看更多